DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE
Saved in:
KOSTEN, T., ET AL., DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE. AMERICAN JOURNAL ON ADDICTIONS, Vol. 14, no. 1 (2005), p. 8-17.
Ref.
132232
Sted:
SIIS R.1264 Archivo
Palabras clave:
Buprenorfina, Cocaína, Desintoxicación, Drogodependencias, Fármacos, Metadona, Resultados, Tests
Buprenorfina, Cocaína, Desintoxicación, Drogodependencias, Fármacos, Metadona, Resultados, Tests
Lignende værker: DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE
- DESIPRAMINE AND CONTINGENCY MANAGEMENT FOR COCAINE AND OPIATE DEPENDENCE IN BUPRENORPHINE MAINTAINED PATIENTS
- DEPRESSION PREDICTS HIGHER RATES OF HEROIN USE ON DESIPRAMINE WITH BUPRENORPHINE THAN WITH METHADONE
- EFFECTS OF REDUCING CONTINGENCY MANAGEMENT VALUES ON HEROIN AND COCAINE USE FOR BUPRENORPHINE- AND DESIPRAMINE-TREATED PATIENTS
- DESIPRAMINE, AMANTADINE, OR FLUOXETINE IN BUPRENORPHINE-MAINTAINED COCAINE USERS
- TIAGABINE INCREASES COCAINE-FREE URINES IN COCAINE-DEPENDENT METHADONE-TREATED PATIENTS. RESULTS OF A RANDOMIZED PILOT STUDY
- AN OPEN TRIAL OF LOW DOSE BUPRENORPHINE IN TREATING METHADONE WITHDRAWAL